Nutex Health reports Q2 results

* Nutex Health press release [https://seekingalpha.com/pr/20207372-nutex-health-provides-financial-reporting-update] (NASDAQ:NUTX [https://seekingalpha.com/symbol/NUTX]): Q2 Revenue of $244M (+220.6% Y/Y) beats by $67.53M.
* Total visits at the Hospital Division were 45,573 for the three months ended June 30, 2025, as compared to 41,208 for the same period in 2024, an increase of 4,365 or 10.6%.
* Visits to mature hospitals increased by 0.6% in the three months ended June 30, 2025, as compared to the same period in 2024.
* For the three months ended June 30, 2025, the Company collected $175 million in cash, the highest collection amount for any quarter.
* Adjusted EBITDA was $71.6 million for the three months ended June 30, 2025, as compared to $6.8 million for the same period in 2024.
* Operating cash flow was $27.1 million for the three months ended June 30, 2025, as compared to $13.3 million for the same period in 2024.

MORE ON NUTEX HEALTH

* Staying On The Sidelines With Nutex Health: Impressive Growth, Serious Doubts Remain [https://seekingalpha.com/article/4808161-staying-on-the-sidelines-with-nutex-health-impressive-growth-serious-doubts-remain]
* Nutex Health: At An Inflection Point [https://seekingalpha.com/article/4801770-nutex-health-at-an-inflection-point]
* Nutex Health: Justified Dilution Given Explosive Growth In Free Cash Flow [https://seekingalpha.com/article/4798251-nutex-health-justified-dilution-given-explosive-growth-in-free-cash-flow]
* Nutex Health down on delayed Q2 financial statements [https://seekingalpha.com/news/4486217-nutex-health-stock-down-delayed-q2-filings]
* Nutex Health reports Q2 results [https://seekingalpha.com/news/4485783-nutex-health-reports-q2-results]